QVT Financial’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-3,763
Closed -$237K 55
2020
Q1
$237K Hold
3,763
0.06% 48
2019
Q4
$466K Hold
3,763
0.09% 46
2019
Q3
$250K Hold
3,763
0.05% 52
2019
Q2
$299K Hold
3,763
0.06% 51
2019
Q1
$421K Sell
3,763
-2,000
-35% -$219K 0.11% 44
2018
Q4
$581K Hold
5,763
0.19% 44
2018
Q3
$728K Hold
5,763
0.19% 43
2018
Q2
$484K Sell
5,763
-5,491
-49% -$402K 0.14% 45
2018
Q1
$692K Sell
11,254
-2,600
-19% -$157K 0.07% 45
2017
Q4
$809K Sell
13,854
-7,000
-34% -$441K 0.05% 54
2017
Q3
$1.21M Sell
20,854
-4,330
-17% -$466K 0.05% 63
2017
Q2
$3.05M Sell
25,184
-30,196
-55% -$3.5M 0.08% 58
2017
Q1
$6.26M Sell
55,380
-6,926
-11% -$809K 0.19% 55
2016
Q4
$6.77M Sell
62,306
-29,575
-32% -$3.52M 0.21% 57
2016
Q3
$15.1M Buy
91,881
+18,638
+25% +$2.94M 0.57% 31
2016
Q2
$10.4M Sell
73,243
-6,801
-8% -$992K 0.72% 42
2016
Q1
$10.3M Buy
80,044
+75,793
+1,783% +$8.95M 0.63% 43
2015
Q4
$635K Hold
4,251
0.04% 80
2015
Q3
$705K Hold
4,251
0.02% 85
2015
Q2
$1.03M Hold
4,251
0.02% 83
2015
Q1
$1.2M Hold
4,251
0.07% 77
2014
Q4
$663K Hold
4,251
0.03% 91
2014
Q3
$1.01M Hold
4,251
0.05% 79
2014
Q2
$1.01M Hold
4,251
0.05% 77
2014
Q1
$1.4M Buy
+4,251
New +$1.43M 0.08% 77

Other funds holding ICPT

QVT Financial's ICPT Position: Q2 2020 in Review

QVT Financial sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2020, closing a stake of 3,763 shares — an estimated $237K sold.

QVT Financial first reported a position in ICPT in Q1 2014 and held it in 25 quarters. The position peaked at $15.1M in Q3 2016. 192 funds tracked by Wall St. Rank hold ICPT as of Q2 2020.

  • QVT Financial reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • QVT Financial sold 3,763 Intercept Pharmaceuticals, Inc. shares in Q2 2020, an estimated $237K.
  • QVT Financial first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2014 and held it in 25 quarters.
  • QVT Financial's Intercept Pharmaceuticals, Inc. position peaked at $15.1M in Q3 2016.
  • 192 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2020.

Based on QVT Financial's 13F filing for Q2 2020, filed 14 Aug 2020.